Donovan G. Kearns

ORCID: 0000-0001-8661-801X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dermatology and Skin Diseases
  • Psoriasis: Treatment and Pathogenesis
  • Allergic Rhinitis and Sensitization
  • Cutaneous Melanoma Detection and Management
  • Autoimmune Bullous Skin Diseases
  • COVID-19 and healthcare impacts
  • Dermatological and COVID-19 studies
  • Drug-Induced Adverse Reactions
  • Cancer Immunotherapy and Biomarkers
  • Cutaneous lymphoproliferative disorders research
  • Diversity and Career in Medicine
  • Immunotherapy and Immune Responses
  • Asthma and respiratory diseases
  • COVID-19 Clinical Research Studies
  • Contact Dermatitis and Allergies
  • Indigenous Studies and Ecology
  • Microscopic Colitis
  • Dermatological and Skeletal Disorders
  • melanin and skin pigmentation
  • Complementary and Alternative Medicine Studies
  • Colorectal and Anal Carcinomas
  • Hidradenitis Suppurativa and Treatments
  • Antifungal resistance and susceptibility
  • Chemotherapy-related skin toxicity
  • Nonmelanoma Skin Cancer Studies

Loma Linda University
2019-2023

Dermatology Research and Education Foundation
2020-2021

Albany Medical Center Hospital
2020-2021

Augusta University
2020-2021

Icahn School of Medicine at Mount Sinai
2020-2021

Boehringer Ingelheim (India)
2020-2021

Regeneron (United States)
2020-2021

Almirall (Spain)
2020-2021

Bristol-Myers Squibb (Germany)
2020-2021

Boehringer Ingelheim (Australia)
2021

To the Editor: As coronavirus disease 2019 pandemic continues to unfold, medical community has been forced make a number of social and institutional adaptations reduce risk patients providers. Changes residency application process are particularly influential on students pursuing competitive specialties such as dermatology. In April 2020, Dermatology Residency Program Directors released consensus statement regarding 2020-2021 cycle.1Dermatology Director Consensus Statement 2020-21...

10.1016/j.jaad.2020.07.011 article EN other-oa Journal of the American Academy of Dermatology 2020-07-08

Abstract Sudden conjunctivitis, lymphopenia, and rash combined with hemodynamic changes (SCoRCH) is a recently described hypersensitivity reaction to trimethoprim–sulfamethoxazole. To date, only 1 case of histologic findings in SCoRCH has been reported, revealing superficial perivascular dermatitis. In this article, we present 53-year-old woman four-day history widespread, confluent, erythematous, dusky after exposure Histologic examination revealed vacuolar interface dermatitis several...

10.1097/dad.0000000000002500 article EN American Journal of Dermatopathology 2023-07-31

Prospective randomized studies have demonstrated a survival benefit of immunotherapy in stage IV cutaneous melanoma. Some retrospective hypothesized synergistic effect radiation and immunotherapy. Our objective was to identify whether there is for patients treated with melanoma the head neck (CMHN). The National Cancer Database used CMHN between 2012 2014. These were stratified based on receipt Adjusted Cox regression analyze overall survival. A total 542 identified CMHN, whom 153 (28%)...

10.1177/000313481908501009 article EN The American Surgeon 2019-10-01

Dermatologists should utilize social media as a platform to post unbiased, evidence-based information regarding manifestations of COVID-19 and guidelines for treatment skin disease during the global pandemic.

10.12788/cutis.0112 article EN Cutis 2020-11-01

Fixed drug eruption (FDE) is a cutaneous reaction that tends to recur in the same area (fixed location) upon re-exposure offending agent. We present 48-year-old woman with FDE being treated for metastatic breast cancer atezolizumab. believe this first reported case of secondary

10.5070/d328157064 article EN cc-by-nc-nd Dermatology Online Journal 2022-04-15

ABSTRACT Teledermatology is a term to describe the provision of dermatologic medical services through telecommunication technology. This teledermatology case red and fissured plaques found within inguinal folds.

10.1097/jdn.0000000000000491 article EN Journal of the Dermatology Nurses’ Association 2019-09-01
Coming Soon ...